sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Anti Viral Therapies Market Scope And Analysis

  • Report Code : TIPRE00014173
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 117
Buy Now

Asia Pacific Anti-Viral Therapies Market Scope and Analysis Report by 2027

Buy Now

Asia Pacific Anti-Viral Therapies Market Report Asia Pacific Anti-Viral Therapies Market Size and Share Asia Pacific Anti-Viral Therapies Market Scope and Analysis

Asia Pacific Anti-Viral Therapies Market Report Scope

Report Attribute Details
Market size in 2019 US$ 8,135.93 Million
Market Size by 2027 US$ 16,118.52 Million
Global CAGR (2020 - 2027) 9.0%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Type
  • Generic Drugs and Branded Drugs
By Mechanism of Action
  • Nucleotide Polymerase Inhibitors
  • Reverse Transcriptase Inhibitors
  • Protease Inhibitors
By Application
  • HIV
  • Hepatitis
  • Virus Influenza
  • Herpes
  • Other Applications
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Aurobindo Pharma Ltd
  • AbbVie Inc
  • GlaxoSmithKline plc
  • AstraZeneca
  • F HOFFMANN LA ROCHE LTD
    		•